Today’s complex biopharmaceuticals and highly personalized medical therapies and devices drive increased complexity in supply chain operations and a growing reliance on contract manufacturing. Contract Manufacturing Organizations (CMO) expansion has made the supply chain harder to manage for both life sciences companies and contract suppliers as both sides manage large numbers of partners with varying processes, standards and information-sharing arrangements. To address this complexity, pharmaceutical and medical device companies must challenge the status quo by transforming the way they collaborate with their contract manufacturers. Our research report delves deeper into the current challenges and how advanced digital technologies can enable a new era of supply chain collaboration.
Pharmaceutical, biotech, and medical device companies and their contract manufacturers know they must improve the way they collaborate with each other. From product development to capacity management, we uncovered their priorities.
The ultimate goal
The ultimate goal is to deliver real patient value with a supply chain transformation powered by collaboration and continuous improvement. Following these 4 steps will help you get there:
Be sure to read our full report to learn more about the key findings and to see real-world examples of supply chain collaboration.